Endometrial cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial cancer}} | {{Endometrial cancer}} | ||
The tumor marker '''[[CA-125]]''' is sometimes checked, since this can predict advanced stage disease.<ref>Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34. PMID 10871446.</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 8: | Line 9: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:22, 4 September 2015
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer laboratory findings |
|
Risk calculators and risk factors for Endometrial cancer laboratory findings |
The tumor marker CA-125 is sometimes checked, since this can predict advanced stage disease.[1]
References
- ↑ Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34. PMID 10871446.